Nachrichten zur Johnson Matthey PLC Aktie

Johnson & Johnson: Hochstufung im Vorfeld des Analystentags - Aktienanalyse

Zürich (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der UBS: Danielle Antalffy, Analystin der UBS, rät in einer aktuellen Aktienanalyse zum Kauf…

Johnson & Johnson: Die Börse bewertet die Übernahme von Laminar positiv - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Johnson &…

Märkte am Morgen: Siemens, Siemens Energy, Fresenius, Bechtle, Tesla, Johnson & Johnson, Elastic

Es läuft wieder rund am deutschen Aktienmarkt. Der November war für den DAX mit einem Plus von 9,5 Prozent der…

Johnson & Johnson: Sleep Well At Night With The Only AAA-Rated Dividend Aristocrat

…

NYSE-Titel J&J-Aktie dennoch fester: Johnson & Johnson veröffentlicht Gewinnwarnung infolge der Laminar-Übernahme

Für die Übernahme floss nach Konzernangaben vom Donnerstag eine Vorauszahlung von 400 Millionen US-Dollar. Dabei falle für den Zukauf ein…

Johnson & Johnson übernimmt Medizintechnikspezialist Laminar

NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson übernimmt den bisher privat geführten Medizintechnikanbieter Laminar und passt…

Johnson & Johnson übernimmt Medizintechnikspezialist Laminar - Ziele angepasst

NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnikkonzern Johnson & Johnson übernimmt den bisher privat geführten Medizintechnikanbieter Laminar…

: Johnson & Johnson buys medical device maker Laminar, cuts full-year earnings guidance

Johnson & Johnson JNJ said Thursday that its medical technology segment has acquired medical device maker Laminar Inc. in a…

Johnson & Johnson slips as Laminar acquisition prompts a profit outlook cut By Investing.com

Johnson & Johnson slips as Laminar acquisition prompts a profit outlook cut…

Johnson & Johnson, Ben Graham, And Defensive Stocks

…

[Latest] Global Organ Transplantation Market Size/Share Worth USD 21.5 Billion by 2032 at a 9.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

Global Rotator Cuff Injury Treatment Market Size To Worth USD 1.66 Billion By 2032 | CAGR of 4.8%

The Rotator Cuff Injury Treatment Market was valued at USD 1.04 Billion in 2022 and the Global Rotator Cuff Injury…

Johnson & Johnson: Kursziel gesenkt

San Francisco (www.aktiencheck.de) - Rating-Update: Larry Biegelsen, Analyst von Wells Fargo Advisors, bewertet die Aktie von Johnson & Johnson (J&J) (ISIN:…

Non-Oncology Biologics and Biosimilars Market is Booming and Expected to Grow at a CAGR of 21.8% to 2031

Companies covered in this report are AbbVie Inc., Sanofi, Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La…

Global Cold Pain Therapy Market Size Worth USD 2.92 Billion by 2032 | CAGR of 5.2%

The Global Cold Pain Therapy Market Size was valued at USD 1.76 Billion in 2022 and the Worldwide Cold Pain…

Global Printing Ink Market Size Worth USD 35.93 Billion by 2032 | CAGR of 6.7%

The Global Cold Pain Therapy Market Size was valued at USD 1.76 Billion in 2022 and the Worldwide Cold Pain…

Johnson & Johnson and Intuitive Surgical Might Become Ozempics Next Victims. Are They Still Worth Buying?

With retailers worrying about Ozempics impact, healthcare stocks could be next.…

[Latest] Global Acne Treatment Market Size/Share Worth USD 18.77 Billion by 2032 at a 6.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

Johnson Matthey Plc (JMPLF) Q2 2024 Earnings Call Transcript

…

Johnson Matthey Plc 2024 Q2 - Results - Earnings Call Presentation

…

Global Endoluminal Suturing Devices Market Size To Worth USD 285.58 Million By 2032 | CAGR of 11.6%

The Endoluminal suturing devices market was valued at USD 95.30 Million in 2022 and the Worldwide endoluminal suturing devices market…

Medical and Surgical Drainage System Market Exclusive Report with Detailed Analysis 2023-2031

Companies covered in this study are B. Braun SE, Becton, Dickinson and Company, Cardinal Health, Inc., Convatec Group Plc, Cook…

Dividend Roundup: General Mills, Nike, Johnson & Johnson, Marriott, and more

…

Johnson & Johnson, STERIS, and Prudential set for ex-dividend By Investing.com

Johnson & Johnson, STERIS, and Prudential set for ex-dividend…

Global Liquid Biopsy Market Size To Worth USD 25.24 Billion By 2032 | CAGR of 11.5%

The Liquid Biopsy Market Size was valued at USD 8.50 Billion in 2022 and the Worldwide liquid biopsy market Size…

IHE: You Better Like Eli Lilly And Johnson & Johnson To Buy This

…

J&J unit laying off dozens in Colorado Springs area as part of restructuring

A new round of layoffs is coming as a unit of health care giant Johnson & Johnson moves to close…

Global Adhesion Barrier Market Size To Grow USD 1786.92 Million by 2032 | CAGR of 7.5%

The Global Adhesion Barrier Market Size was valued at USD 646.5 Million in 2022 and The Worldwide Adhesion Barrier Market…

Johnson & Johnson produces documents in DoJ civil investigation of eye products

Johnson & Johnson has begun providing documents and information in response to a civil investigation by the U.S. Department of…

Johnson & Johnson produces documents in DoJ civil investigation of eye products By Reuters

Johnson & Johnson produces documents in DoJ civil investigation of eye products…

VTV: A Must-Watch ETF for Value Investors

Value investing may not sound as exciting as investing in the next hot growth stock, but it’s a time-honored investing…

3 High-Yielding Dividend Stocks Near Their 52-Week Lows

Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right…

3 High-Yielding Dividend Stocks Near Their 52-Week Lows @themotleyfool #stocks $JNJ $BAC $WMT $TGT

Due to their declining share prices, Johnson & Johnson, Bank of America, and Target all yield more than 3% right…

Johnson & Johnson inks licensing deal with Quanterix for Alzheimers testing

…

Johnson & Johnson: Kursziel erhöht

London (www.aktiencheck.de) - Rating-Update: Die Analysten von Barclays stufen die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046, WKN: 853260, Ticker-Symbol:…

Johnson & Johnson: Q3 Earnings Unveils Life After Kenvue Spinoff

…

Johnson & Johnson: Kursziel gekürzt

New York (www.aktiencheck.de) - Rating-Update: Terence Flynn, Analyst von Morgan Stanley, bewertet die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046,…

wikifolio whispers a.m. Qualcomm Incorporated, Roche Holding , Johnson & Johnson ...

Qualcomm Incorporated -0.22% gerihouse (BRANDZ10): Der amerikanische Technologiekonzern Qualcomm Inc. (ISIN: US7475251036, NASDAQ: QCOM) schüttet eine Quartalsdividende in Höhe von…

Johnson & Johnson: Alles in allem robustes Ergebnis im 3. Quartal - Prognose für 2023 leicht angehoben - Aktienanalyse

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript

JNJ earnings call for the period ending September 30, 2023.…

Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript

…

Johnson & Johnson sees GLP-1 impact on weight loss surgeries

…

J&J-Aktie an der NYSE dennoch in Rot: Johnson & Johnson blickt auf starkes Quartal zurück - Prognose angehoben

Zwischen Juli und September profitierte das Unternehmen vor allem von einem starken Medizintechnikgeschäft. Aber auch die Pharmasparte konnte zulegen, wie…

Johnson & Johnson: Unerwartet gute Quartalszahlen! Aktienanalyse

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

Johnson & Johnson: Pharma-Segment übertrifft Erwartungen - Aktienanalyse

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Opening Bell: Starke Wirtschaftsdaten belasten Wall Street; US-Anleihen, Gold, Johnson&Johnson, Bank of America, Goldman Sachs, Apple im Fokus

Nach einem positiven Wochenstart stehen die Zeichen an den US-Börsen am Dienstag zunächst wieder auf Konsolidierung. Der Leitindex Dow Jones…

dpa-AFX ProFeed